187 related articles for article (PubMed ID: 37914786)
21. Prognostic and Predictive Value of Circulating and Disseminated Tumor Cells in Breast Cancer: A National Cancer Database (NCDB) Analysis.
Bilani N; Elson L; Liang H; Elimimian EB; Arteta-Bulos R; Nahleh Z
Technol Cancer Res Treat; 2020; 19():1533033820980107. PubMed ID: 33287661
[TBL] [Abstract][Full Text] [Related]
22. EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression.
Satelli A; Batth I; Brownlee Z; Mitra A; Zhou S; Noh H; Rojas CR; Li H; Meng QH; Li S
Oncotarget; 2017 Jul; 8(30):49329-49337. PubMed ID: 28521303
[TBL] [Abstract][Full Text] [Related]
23. Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9.
Chu HY; Yang CY; Yeh PH; Hsu CJ; Chang LW; Chan WJ; Lin CP; Lyu YY; Wu WC; Lee CW; Wu JK; Jiang JK; Tseng FG
Cells; 2021 May; 10(5):. PubMed ID: 34068719
[TBL] [Abstract][Full Text] [Related]
24. Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response.
Satelli A; Brownlee Z; Mitra A; Meng QH; Li S
Clin Chem; 2015 Jan; 61(1):259-66. PubMed ID: 25336717
[TBL] [Abstract][Full Text] [Related]
25. Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer.
Tan W; Liang G; Xie X; Jiang W; Tan L; Sanders AJ; Liu Z; Ling Y; Zhong W; Tian Z; Lin W; Gong C
Oncologist; 2019 Nov; 24(11):e1044-e1054. PubMed ID: 31300482
[TBL] [Abstract][Full Text] [Related]
26. Circulating tumor cells are a good predictor of tumor recurrence in clinical patients with gastric cancer.
Li W; Zhang X; Yang Y; Lin J; Zhou K; Sun R; Dang C; Diao D
Sci Rep; 2024 Jun; 14(1):12758. PubMed ID: 38830909
[TBL] [Abstract][Full Text] [Related]
27. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
[TBL] [Abstract][Full Text] [Related]
28. The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis.
Tan Y; Wu H
Curr Probl Cancer; 2018; 42(1):95-106. PubMed ID: 29277243
[TBL] [Abstract][Full Text] [Related]
29. Comparison of circulating tumor cell (CTC) detection rates with epithelial cell adhesion molecule (EpCAM) and cell surface vimentin (CSV) antibodies in different solid tumors: a retrospective study.
Gao Y; Fan WH; Song Z; Lou H; Kang X
PeerJ; 2021; 9():e10777. PubMed ID: 33717672
[TBL] [Abstract][Full Text] [Related]
30. The Number of Intraoperative Intestinal Venous Circulating Tumor Cells Is a Prognostic Factor for Colorectal Cancer Patients.
Liu Z; Gu Y; Yu F; Zhou L; Cheng X; Jiang H; Huang Y; Zhang Y; Xu T; Qian W; Li X
Evid Based Complement Alternat Med; 2022; 2022():4162354. PubMed ID: 36193123
[TBL] [Abstract][Full Text] [Related]
31. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of circulating tumour cells and tumour marker detection in the chemotherapeutic evaluation of advanced colorectal cancer.
Shen F; Zhu Y; Wang F; Cai X; Ding H; Zhou F; Wang J; Gu H; Liu C; Li Q
Colorectal Dis; 2022 Jan; 24(1):68-76. PubMed ID: 34611964
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients.
Shimada R; Iinuma H; Akahane T; Horiuchi A; Watanabe T
Oncol Rep; 2012 Apr; 27(4):947-53. PubMed ID: 22267181
[TBL] [Abstract][Full Text] [Related]
34. Clinical Potential of Circulating Tumor Cells in Colorectal Cancer: A Prospective Study.
Baek DH; Kim GH; Song GA; Han IS; Park EY; Kim HS; Jo HJ; Ko SH; Park DY; Cho YK
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00055. PubMed ID: 31246593
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the diagnostic value of circulating tumor cells with CytoSorter
Jin L; Zhao W; Zhang J; Chen W; Xie T; Wang L; Fan W; Xie S; Shen J; Zheng H; Hu W; Wei Q; Dong M; Wang Q; Shen J; Liu Y
Cancer Med; 2020 Mar; 9(5):1638-1647. PubMed ID: 31908156
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" Trial.
Riethdorf S; Müller V; Loibl S; Nekljudova V; Weber K; Huober J; Fehm T; Schrader I; Hilfrich J; Holms F; Tesch H; Schem C; von Minckwitz G; Untch M; Pantel K
Clin Cancer Res; 2017 Sep; 23(18):5384-5393. PubMed ID: 28679772
[No Abstract] [Full Text] [Related]
37. MiSelect R System: the validation of a new detection system of CTCs and their correlation with prognosis in non-metastatic CRC patients.
Lin CC; Yang CY; Hung TC; Wang CH; Wei SW; Schiro P; Tseng JY; Lin CH; Jiang JK
Sci Rep; 2023 Mar; 13(1):4773. PubMed ID: 36959311
[TBL] [Abstract][Full Text] [Related]
38. Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer.
Sotelo MJ; Sastre J; Maestro ML; Veganzones S; Viéitez JM; Alonso V; Grávalos C; Escudero P; Vera R; Aranda E; García-Alfonso P; Gallego-Plazas J; Lopez C; Pericay C; Arrivi A; Vicente P; Ballesteros P; Elez E; López-Ladrón A; Díaz-Rubio E
Ann Oncol; 2015 Mar; 26(3):535-41. PubMed ID: 25515656
[TBL] [Abstract][Full Text] [Related]
39. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.
Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X
Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836
[TBL] [Abstract][Full Text] [Related]
40. Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer.
Wu F; Zhu J; Mao Y; Li X; Hu B; Zhang D
Dis Markers; 2017; 2017():9474532. PubMed ID: 29430076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
